Data Bridge Market Research analyses that the precision medicine market was valued at USD 58.29 billion in 2021 and is expected to reach USD 145.36 billion by 2029, registering a CAGR of 12.10% during the forecast period of 2022 to 2029.

The Precision Medicine Market report assists to attain an extreme sense of evolving industry movements before the competitors. The report presents the data and information for actionable, most modern and real-time market insights about Precision Medicine Market industry which makes it easy to take critical business decisions. New possibilities are offered via this Precision Medicine Market report to explore which are made feasible by superior research methodologies, research tools and rich experiences. Besides, this business report offers historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. Global Precision Medicine Market research document gives strength to any kind of business whether it is large, medium or small for surviving and succeeding in the market.

Get Sample PDF of Precision Medicine Market Report (including COVID19 Impact Analysis)@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=glo...

Precision Medicine Market Dynamics

Drivers

Increasing prevalence of CNS disorders

Rise in the prevalence of cancer

Opportunities

Growing number of R&D activities

Restraints/Challenges Global Precision Medicine Market

High cost associated with diagnosis and precision medicine

Key Players: Global Precision Medicine Market

Moderna, Inc. (MA), PERSONALIS INC. (US), GENOCEA BIOSCIENCES, INC (US), CureVac AG (Germany), CELLDEX THERAPEUTICS (US), BIONTECH SE (Rhineland-Palatinate), Advaxis, Inc. (US), Agenus Inc. (US), Immatics Biotechnologies GmbH (Germany), Gritstone Oncology (US), NantKwest, Inc. (US), bioMérieux SA (France), Bayer AG (Germany), Pfizer Inc. (US), GlaxoSmithKline plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (US)

MAJOR TOC OF THE REPORT

Chapter One: Precision Medicine Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Precision Medicine Market Competition, by Players

Chapter Four: Global Precision Medicine Market Size by Application (Diagnostics, Therapeutics, Others)

Chapter Five: Global Precision Medicine Market Revenue by Technologies (Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Others)

Chapter Six: Global Precision Medicine Market Revenue by Indication (Oncology, Central Nervous System (CNS) Disorders, Immunology Disorders, Respiratory Disorders, Others)

Chapter Seven: Global Precision Medicine Market Revenue by Drugs (Alectinib, Osimertinib, Mepolizumab, Aripiprazole Lauroxil, Others)

Chapter Eight: Global Precision Medicine Market Revenue by Route of Administration (Oral, Injectable)

Chapter Nine: Global Precision Medicine Market Revenue by End Users (Hospitals, Homecare, Specialty Clinics, Others)

Get Detail TOC@ https://www.databridgemarketresearch.com/toc/?dbmr=global-precision...

Key Report Highlights

Deep insights about regulatory and investment scenarios of the global Precision Medicine Market

Analysis of market effect factors and their impact on the forecast and outlook of the global Precision Medicine Market

The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the global Precision Medicine Market

A roadmap of growth opportunities available in the Global Precision Medicine Marketwith the identification of key factors

The exhaustive analysis of various trends of the Global Precision Medicine Marketto help identify market developments

Key Questions Answered in Report:

What is the key to the Precision Medicine Market?

What will the Precision Medicine Market Demand and what will be Growth?

What are the latest opportunities for Precision Medicine Market in the future?

What are the strengths of the key players?

Which region accounted for the largest Precision Medicine Market share?